|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q42196420
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241121000043.0 |
|
008
|
|
|
241121nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q42196420
|
|
024
|
|
|
‡a
0000-0002-7444-9359
‡2
orcid
|
|
024
|
|
|
‡a
55967922900
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q42196420
|
|
100
|
0 |
|
‡a
Miquéias Lopes-Pacheco
‡9
sl
|
|
400
|
0 |
|
‡a
Miquéias Lopes-Pacheco
‡c
researcher
‡9
en
|
|
400
|
0 |
|
‡a
Miquéias Lopes-Pacheco
‡c
wetenschapper
‡9
nl
|
|
400
|
0 |
|
‡a
Miquéias Lopes-Pacheco
‡c
investigador/a
‡9
es
|
|
400
|
0 |
|
‡a
Miquéias Lopes-Pacheco
‡c
investigador
‡9
ast
|
|
670
|
|
|
‡a
Author's Association with Amino Acids Does Not Enhance Efficacy of Polymerized Liposomes As a System for Lung Gene Delivery
|
|
670
|
|
|
‡a
Author's Cell-Based Therapy for Silicosis
|
|
670
|
|
|
‡a
Author's CFTR interactome mapping using the mammalian membrane two-hybrid high-throughput screening system
|
|
670
|
|
|
‡a
Author's CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis
|
|
670
|
|
|
‡a
Author's CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
|
|
670
|
|
|
‡a
Author's Combination of Correctors Rescue ΔF508-CFTR by Reducing Its Association with Hsp40 and Hsp27.
|
|
670
|
|
|
‡a
Author's Combination of Correctors Rescues CFTR Transmembrane-Domain Mutants by Mitigating their Interactions with Proteostasis
|
|
670
|
|
|
‡a
Author's Correctors Rescue CFTR Mutations in Nucleotide-Binding Domain 1 (NBD1) by Modulating Proteostasis.
|
|
670
|
|
|
‡a
Author's Current understanding of the immunosuppressive properties of mesenchymal stromal cells
|
|
670
|
|
|
‡a
Author's Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome
|
|
670
|
|
|
‡a
Author's Dasatinib Reduces Lung Inflammation and Fibrosis in Acute Experimental Silicosis
|
|
670
|
|
|
‡a
Author's Editorial: Emerging Therapeutic Approaches for Cystic Fibrosis
|
|
670
|
|
|
‡a
Author's Effects of bone marrow-derived mononuclear cells from healthy or acute respiratory distress syndrome donors on recipient lung-injured mice.
|
|
670
|
|
|
‡a
Author's Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema
|
|
670
|
|
|
‡a
Author's Effects of mesenchymal stromal cells play a role the oxidant/antioxidant balance in a murine model of asthma.
|
|
670
|
|
|
‡a
Author's Eicosapentaenoic Acid Enhances the Effects of Mesenchymal Stromal Cell Therapy in Experimental Allergic Asthma.
|
|
670
|
|
|
‡a
Author's Eicosapentaenoic acid potentiates the therapeutic effects of adipose tissue-derived mesenchymal stromal cells on lung and distal organ injury in experimental sepsis
|
|
670
|
|
|
‡a
Author's Impact of different intratracheal flows during lung decellularization on extracellular matrix composition and mechanics
|
|
670
|
|
|
‡a
Author's Impact of one versus two doses of mesenchymal stromal cells on lung and cardiovascular repair in experimental emphysema
|
|
670
|
|
|
‡a
Author's Increases in cytosolic Ca2+ induce dynamin- and calcineurin-dependent internalisation of CFTR
|
|
670
|
|
|
‡a
Author's Infusion of bone marrow mononuclear cells reduces lung fibrosis but not inflammation in the late stages of murine silicosis
|
|
670
|
|
|
‡a
Author's Mesenchymal Stem Cells From Bone Marrow, Adipose Tissue, and Lung Tissue Differentially Mitigate Lung and Distal Organ Damage in Experimental Acute Respiratory Distress Syndrome.
|
|
670
|
|
|
‡a
Author's Mesenchymal Stromal Cells Are More Effective Than Their Extracellular Vesicles at Reducing Lung Injury Regardless of Acute Respiratory Distress Syndrome Etiology
|
|
670
|
|
|
‡a
Author's Mesenchymal Stromal Cells From Emphysematous Donors and Their Extracellular Vesicles Are Unable to Reverse Cardiorespiratory Dysfunction in Experimental Severe Emphysema
|
|
670
|
|
|
‡a
Author's Moderate Aerobic Training Improves Cardiorespiratory Parameters in Elastase-Induced Emphysema
|
|
670
|
|
|
‡a
Author's Multiple doses of adipose tissue-derived mesenchymal stromal cells induce immunosuppression in experimental asthma
|
|
670
|
|
|
‡a
Author's Pilot safety study of intrabronchial instillation of bone marrow-derived mononuclear cells in patients with silicosis
|
|
670
|
|
|
‡a
Author's Repeated administration of bone marrow-derived cells prevents disease progression in experimental silicosis.
|
|
670
|
|
|
‡a
Author's Rescue of NBD2 mutants N1303K and S1235R of CFTR by small-molecule correctors and transcomplementation
|
|
670
|
|
|
‡a
Author's Rescuing Trafficking Mutants of the ATP-binding Cassette Protein, ABCA4, with Small Molecule Correctors as a Treatment for Stargardt Eye Disease.
|
|
670
|
|
|
‡a
Author's Self-complementary and tyrosine-mutant rAAV vectors enhance transduction in cystic fibrosis bronchial epithelial cells
|
|
670
|
|
|
‡a
Author's Serum from Asthmatic Mice Potentiates the Therapeutic Effects of Mesenchymal Stromal Cells in Experimental Allergic Asthma
|
|
670
|
|
|
‡a
Author's Single tyrosine mutation in AAV8 vector capsid enhances gene lung delivery and does not alter lung morphofunction in mice.
|
|
670
|
|
|
‡a
Author's Therapeutic effects of bone marrow-derived mononuclear cells from healthy or silicotic donors on recipient silicosis mice
|
|
670
|
|
|
‡a
Author's Therapeutic effects of LASSBio-596 in an elastase-induced mouse model of emphysema
|
|
909
|
|
|
‡a
(scopus) 55967922900
‡9
1
|
|
909
|
|
|
‡a
(orcid) 0000000274449359
‡9
1
|
|
919
|
|
|
‡a
mesenchymalstemcellsfrombonemarrowadiposetissueandlungtissuedifferentiallymitigatelunganddistalorgandamageinexperimentalacuterespiratorydistresssyndrome
‡A
Mesenchymal Stem Cells From Bone Marrow, Adipose Tissue, and Lung Tissue Differentially Mitigate Lung and Distal Organ Damage in Experimental Acute Respiratory Distress Syndrome.
‡9
1
|
|
919
|
|
|
‡a
infusionofbonemarrowmononuclearcellsreduceslungfibrosisbutnotinflammationinthelatestagesofmurinesilicosis
‡A
Infusion of bone marrow mononuclear cells reduces lung fibrosis but not inflammation in the late stages of murine silicosis
‡9
1
|
|
919
|
|
|
‡a
increasesincytosolicca2+inducedynaminandcalcineurindependentinternalisationofcftr
‡A
Increases in cytosolic Ca2+ induce dynamin- and calcineurin-dependent internalisation of CFTR
‡9
1
|
|
919
|
|
|
‡a
impactof1versus2dosesofmesenchymalstromalcellsonlungandcardiovascularrepairinexperimentalemphysema
‡A
Impact of one versus two doses of mesenchymal stromal cells on lung and cardiovascular repair in experimental emphysema
‡9
1
|
|
919
|
|
|
‡a
impactofdifferentintratrachealflowsduringlungdecellularizationonextracellularmatrixcompositionandmechanics
‡A
Impact of different intratracheal flows during lung decellularization on extracellular matrix composition and mechanics
‡9
1
|
|
919
|
|
|
‡a
eicosapentaenoicacidpotentiatesthetherapeuticeffectsofadiposetissuederivedmesenchymalstromalcellsonlunganddistalorganinjuryinexperimentalsepsis
‡A
Eicosapentaenoic acid potentiates the therapeutic effects of adipose tissue-derived mesenchymal stromal cells on lung and distal organ injury in experimental sepsis
‡9
1
|
|
919
|
|
|
‡a
eicosapentaenoicacidenhancestheeffectsofmesenchymalstromalcelltherapyinexperimentalallergicasthma
‡A
Eicosapentaenoic Acid Enhances the Effects of Mesenchymal Stromal Cell Therapy in Experimental Allergic Asthma.
‡9
1
|
|
919
|
|
|
‡a
effectsofmesenchymalstromalcellsplayaroletheoxidantantioxidantbalanceinamurinemodelofasthma
‡A
Effects of mesenchymal stromal cells play a role the oxidant/antioxidant balance in a murine model of asthma.
‡9
1
|
|
919
|
|
|
‡a
effectsofdifferentmesenchymalstromalcellsourcesanddeliveryroutesinexperimentalemphysema
‡A
Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema
‡9
1
|
|
919
|
|
|
‡a
effectsofbonemarrowderivedmononuclearcellsfromhealthyoracuterespiratorydistresssyndromedonorsonrecipientlunginjuredmice
‡A
Effects of bone marrow-derived mononuclear cells from healthy or acute respiratory distress syndrome donors on recipient lung-injured mice.
‡9
1
|
|
919
|
|
|
‡a
editorialemergingtherapeuticapproachesforcysticfibrosis
‡A
Editorial: Emerging Therapeutic Approaches for Cystic Fibrosis
‡9
1
|
|
919
|
|
|
‡a
dasatinibreduceslunginflammationandfibrosisinacuteexperimentalsilicosis
‡A
Dasatinib Reduces Lung Inflammation and Fibrosis in Acute Experimental Silicosis
‡9
1
|
|
919
|
|
|
‡a
currentunderstandingofthetherapeuticbenefitsofmesenchymalstemcellsinacuterespiratorydistresssyndrome
‡A
Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome
‡9
1
|
|
919
|
|
|
‡a
currentunderstandingoftheimmunosuppressivepropertiesofmesenchymalstromalcells
‡A
Current understanding of the immunosuppressive properties of mesenchymal stromal cells
‡9
1
|
|
919
|
|
|
‡a
correctorsrescuecftrmutationsinnucleotidebindingdomain1nbd1bymodulatingproteostasis
‡A
Correctors Rescue CFTR Mutations in Nucleotide-Binding Domain 1 (NBD1) by Modulating Proteostasis.
‡9
1
|
|
919
|
|
|
‡a
combinationofcorrectorsrescuescftrtransmembranedomainmutantsbymitigatingtheirinteractionswithproteostasis
‡A
Combination of Correctors Rescues CFTR Transmembrane-Domain Mutants by Mitigating their Interactions with Proteostasis
‡9
1
|
|
919
|
|
|
‡a
combinationofcorrectorsrescueδf508cftrbyreducingitsassociationwithhsp40andhsp27
‡A
Combination of Correctors Rescue ΔF508-CFTR by Reducing Its Association with Hsp40 and Hsp27.
‡9
1
|
|
919
|
|
|
‡a
cftrmodulatorsthechangingfaceofcysticfibrosisintheeraofprecisionmedicine
‡A
CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
‡9
1
|
|
919
|
|
|
‡a
cftrmodulatorssheddinglightonprecisionmedicineforcysticfibrosis
‡A
CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis
‡9
1
|
|
919
|
|
|
‡a
serumfromasthmaticmicepotentiatesthetherapeuticeffectsofmesenchymalstromalcellsinexperimentalallergicasthma
‡A
Serum from Asthmatic Mice Potentiates the Therapeutic Effects of Mesenchymal Stromal Cells in Experimental Allergic Asthma
‡9
1
|
|
919
|
|
|
‡a
cftrinteractomemappingusingthemammalianmembrane2hybridhighthroughputscreeningsystem
‡A
CFTR interactome mapping using the mammalian membrane two-hybrid high-throughput screening system
‡9
1
|
|
919
|
|
|
‡a
cellbasedtherapyforsilicosis
‡A
Cell-Based Therapy for Silicosis
‡9
1
|
|
919
|
|
|
‡a
associationwithaminoacidsdoesnotenhanceefficacyofpolymerizedliposomesasasystemforlunggenedelivery
‡A
Association with Amino Acids Does Not Enhance Efficacy of Polymerized Liposomes As a System for Lung Gene Delivery
‡9
1
|
|
919
|
|
|
‡a
mesenchymalstromalcellsfromemphysematousdonorsandtheirextracellularvesiclesareunabletoreversecardiorespiratorydysfunctioninexperimentalsevereemphysema
‡A
Mesenchymal Stromal Cells From Emphysematous Donors and Their Extracellular Vesicles Are Unable to Reverse Cardiorespiratory Dysfunction in Experimental Severe Emphysema
‡9
1
|
|
919
|
|
|
‡a
moderateaerobictrainingimprovescardiorespiratoryparametersinelastaseinducedemphysema
‡A
Moderate Aerobic Training Improves Cardiorespiratory Parameters in Elastase-Induced Emphysema
‡9
1
|
|
919
|
|
|
‡a
multipledosesofadiposetissuederivedmesenchymalstromalcellsinduceimmunosuppressioninexperimentalasthma
‡A
Multiple doses of adipose tissue-derived mesenchymal stromal cells induce immunosuppression in experimental asthma
‡9
1
|
|
919
|
|
|
‡a
pilotsafetystudyofintrabronchialinstillationofbonemarrowderivedmononuclearcellsinpatientswithsilicosis
‡A
Pilot safety study of intrabronchial instillation of bone marrow-derived mononuclear cells in patients with silicosis
‡9
1
|
|
919
|
|
|
‡a
repeatedadministrationofbonemarrowderivedcellspreventsdiseaseprogressioninexperimentalsilicosis
‡A
Repeated administration of bone marrow-derived cells prevents disease progression in experimental silicosis.
‡9
1
|
|
919
|
|
|
‡a
rescueofnbd2mutantsn1303kands1235rofcftrbysmallmoleculecorrectorsandtranscomplementation
‡A
Rescue of NBD2 mutants N1303K and S1235R of CFTR by small-molecule correctors and transcomplementation
‡9
1
|
|
919
|
|
|
‡a
rescuingtraffickingmutantsoftheatpbindingcassetteproteinabca4withsmallmoleculecorrectorsasatreatmentforstargardteyedisease
‡A
Rescuing Trafficking Mutants of the ATP-binding Cassette Protein, ABCA4, with Small Molecule Correctors as a Treatment for Stargardt Eye Disease.
‡9
1
|
|
919
|
|
|
‡a
selfcomplementaryandtyrosinemutantraavvectorsenhancetransductionincysticfibrosisbronchialepithelialcells
‡A
Self-complementary and tyrosine-mutant rAAV vectors enhance transduction in cystic fibrosis bronchial epithelial cells
‡9
1
|
|
919
|
|
|
‡a
mesenchymalstromalcellsaremoreeffectivethantheirextracellularvesiclesatreducinglunginjuryregardlessofacuterespiratorydistresssyndromeetiology
‡A
Mesenchymal Stromal Cells Are More Effective Than Their Extracellular Vesicles at Reducing Lung Injury Regardless of Acute Respiratory Distress Syndrome Etiology
‡9
1
|
|
919
|
|
|
‡a
singletyrosinemutationinaav8vectorcapsidenhancesgenelungdeliveryanddoesnotalterlungmorphofunctioninmice
‡A
Single tyrosine mutation in AAV8 vector capsid enhances gene lung delivery and does not alter lung morphofunction in mice.
‡9
1
|
|
919
|
|
|
‡a
therapeuticeffectsofbonemarrowderivedmononuclearcellsfromhealthyorsilicoticdonorsonrecipientsilicosismice
‡A
Therapeutic effects of bone marrow-derived mononuclear cells from healthy or silicotic donors on recipient silicosis mice
‡9
1
|
|
919
|
|
|
‡a
therapeuticeffectsoflassbio596inanelastaseinducedmousemodelofemphysema
‡A
Therapeutic effects of LASSBio-596 in an elastase-induced mouse model of emphysema
‡9
1
|
|
996
|
|
|
‡2
PTBNP|143818
|
|
996
|
|
|
‡2
NSK|000275127
|
|
996
|
|
|
‡2
SUDOC|174925476
|
|
996
|
|
|
‡2
PTBNP|76938
|
|
996
|
|
|
‡2
LC|no 00001800
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
